165 related articles for article (PubMed ID: 30032527)
21. The natural history of resected pancreatic cancer without adjuvant chemotherapy.
Hernandez JM; Morton CA; Al-Saadi S; Villadolid D; Cooper J; Bowers C; Rosemurgy AS
Am Surg; 2010 May; 76(5):480-5. PubMed ID: 20506876
[TBL] [Abstract][Full Text] [Related]
22. [Surgical management of pancreatic cancer].
Kim SC
Korean J Gastroenterol; 2008 Feb; 51(2):89-100. PubMed ID: 18349571
[TBL] [Abstract][Full Text] [Related]
23. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
[TBL] [Abstract][Full Text] [Related]
24. [Prospects for standardization of surgical procedures for carcinoma of the pancreas].
Wataru K
Nihon Geka Gakkai Zasshi; 2003 May; 104(5):412-21. PubMed ID: 12774526
[TBL] [Abstract][Full Text] [Related]
25. Multimodality management of borderline resectable pancreatic adenocarcinoma.
Prakash LR; Katz MHG
Chin Clin Oncol; 2017 Jun; 6(3):27. PubMed ID: 28705004
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.
Barenboim A; Lahat G; Geva R; Nachmany I; Nakache R; Goykhman Y; Brazowski E; Rosen G; Isakov O; Wolf I; Klausner JM; Lubezky N
Eur J Surg Oncol; 2018 Oct; 44(10):1619-1623. PubMed ID: 30146251
[TBL] [Abstract][Full Text] [Related]
27. Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan.
Satoi S; Murakami Y; Motoi F; Sho M; Matsumoto I; Uemura K; Kawai M; Kurata M; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Kinoshita S; Akahori T; Shinzeki M; Fukumoto T; Hashimoto Y; Hirono S; Yamaue H; Honda G; Kwon M
Pancreas; 2016 Aug; 45(7):1003-9. PubMed ID: 26692442
[TBL] [Abstract][Full Text] [Related]
28. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.
Stojadinovic A; Brooks A; Hoos A; Jaques DP; Conlon KC; Brennan MF
J Am Coll Surg; 2003 Jun; 196(6):954-64. PubMed ID: 12788434
[TBL] [Abstract][Full Text] [Related]
29. Duration of Preoperative Biliary Drainage as a Prognostic Factor After Pancreaticoduodenectomy for Pancreatic Head Cancer.
Matsumoto M; Nakabayashi Y; Fujiwara Y; Funamizu N; Noaki R; Eto S; Sugano H; Otsuka M; Yanaga K
Anticancer Res; 2017 Jun; 37(6):3215-3219. PubMed ID: 28551667
[TBL] [Abstract][Full Text] [Related]
30. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
31. [Interpretation of the guidelines for neoadjuvant therapy of pancreatic cancer in China(2020 edition)].
Qiu JD; Zhu RZ; Chen H; Zhang TP
Zhonghua Wai Ke Za Zhi; 2021 Mar; 59(3):232-236. PubMed ID: 33685058
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic adenocarcinoma.
Eskander MF; Bliss LA; Tseng JF
Curr Probl Surg; 2016 Mar; 53(3):107-54. PubMed ID: 26923296
[No Abstract] [Full Text] [Related]
33. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
[TBL] [Abstract][Full Text] [Related]
34. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
35. ERT following IORT improves survival of patients with resectable pancreatic cancer.
Yamaguchi K; Nakamura K; Kobayashi K; Nakano K; Konomi H; Mizumoto K; Tanaka M
Hepatogastroenterology; 2005; 52(64):1244-9. PubMed ID: 16001672
[TBL] [Abstract][Full Text] [Related]
36. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome.
Lekkerkerker SJ; Besselink MG; Busch OR; Verheij J; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
Gastrointest Endosc; 2017 May; 85(5):1025-1031. PubMed ID: 27693645
[TBL] [Abstract][Full Text] [Related]
37. [Guidelines for the diagnosis and treatment of pancreatic cancer in China(2021)].
Chinese Pancreatic Surgery Association, Chinese Society of Surgery, Chinese Medical Association
Zhonghua Wai Ke Za Zhi; 2021 Jul; 59(7):561-577. PubMed ID: 34256456
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.
Marchegiani G; Andrianello S; Nessi C; Sandini M; Maggino L; Malleo G; Paiella S; Polati E; Bassi C; Salvia R
Ann Surg Oncol; 2018 Mar; 25(3):626-637. PubMed ID: 29214453
[TBL] [Abstract][Full Text] [Related]
39. New challenges in perioperative management of pancreatic cancer.
Puleo F; Maréchal R; Demetter P; Bali MA; Calomme A; Closset J; Bachet JB; Deviere J; Van Laethem JL
World J Gastroenterol; 2015 Feb; 21(8):2281-93. PubMed ID: 25741134
[TBL] [Abstract][Full Text] [Related]
40. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
